Login / Signup

Higher Febuxostat Exposure Observed in Asian Compared with Caucasian Subjects Independent of Bodyweight.

Dinko RekićSusanne JohanssonJacob Leander
Published in: Clinical pharmacokinetics (2020)
In this pooled analysis of three studies, we show that Asian individuals have a 1.64-fold higher febuxostat exposure than Caucasians, independent of bodyweight or other investigated covariates. These findings may be of importance when selecting starting febuxostat doses in Asian patients.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • clinical trial
  • african american
  • patient reported outcomes
  • atomic force microscopy
  • high resolution